The above information was shared by Fortune Business Insights in a report, titled “Nebulizers Market Size, Share and Global Trend by Product (Pneumatic Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers, Others), By End-User (Clinics, Hospitals, Ambulatory Surgery Centres, Home Care Settings, Others), and Geography Forecast till 2026.” A nebulizer is a medical device which helps to treat asthma by converting different drugs into vapours and later delivering it to the lungs. Not only asthma, but nebulization also helps in the treatment of other respiratory disorders such as cystic fibrosis.
The Global Burden of Disease Study has found that around 251 million people in the world were affected by Chronic Obstructive Pulmonary Disease or COPD in 2016. This will fuel demand for nebulizers, driving the global nebulizers market.
Get Sample PDF Brochure at
Some of the major companies that are present in the Global Nebulizers Market are
- OMRON Corporation
- Koninklijke Philips N.V.
- Dickinson and Company
- Allied Healthcare
- Agilent Technologies, Inc.
- Medline Industries, Inc. and Briggs Healthcare and others.
The demand for different types of nebulizer products such as ultrasonic nebulizers, pneumatic nebulizers, mesh nebulizers, and others is increasing. Of these, a pneumatic nebulizer was leading the global market and is anticipated to maintain its dominance through the forecast years.
The rising prevalence of respiratory disorders especially among the aged population is driving the segment’s growth. Considering this, the global nebulizers market share is expected to increase in the forecast years.
Market Sees Growth Owing to Rising Adoption of Technologically-advanced Medical Devices in North America
Rising geriatric population in North America is resulting in an increasing number of surgeries and respiratory diseases. This will boost the nebulizers market size in North America. As per a study conducted by the Center for Diseases Control and Prevention, people in the U.S. suffered deaths in 2014, as COPD was the third-leading disease for these deaths.
The market was leading in the year 2018 on account of mounting pollution levels and increasing healthcare expenditure. Another factor responsible for growth is the rising adoption of technologically-advanced medical devices and equipment.
The market in Asia Pacific is expected to grow considerably during the forecast period. Increasing cases of respiratory disorders and rising geriatric population are primary factors enabling growth in the market. Countries such as India and China have high pollution levels, which increases the prevalence of respiratory diseases. Enabled by this, the demand for nebulizer machines is increasing in Asia Pacific. This will further positively impact nebulizers market growth.
Rising disposable income among people and growing awareness about diseases in this region are potential growth triggers in the market. As per the Institute for Health Metrics and Evaluation, the number of COPD cases in Japan increased by 24.2% between 2005 and 2016. Hence, the rising prevalence of respiratory disorders is expected to drive the nebulizers market size in Asia Pacific.
- Pneumatic Nebulizers
- Ultrasonic Nebulizers
- Mesh Nebulizers
By End User
- Ambulatory Surgery Centres
- Home Care Settings
Rising Demand for Home Care Therapeutics Contributes to the Growth
Unhealthy eating, obesity, high alcohol and tobacco consumption, and absence of physical activity are factors leading to a high prevalence of respiratory diseases. This, in turn, will propel growth in the market. The nebulizers market revenue is likely to increase on account of rising demand for home healthcare. This allows patients to conveniently use nebulizers machines and medicines at home.
Speak To Analyst at
Home healthcare is less expensive as compared to hospital stays, which boosts the market. The adoption of nebulizers in home healthcare is increasing owing to their easy availability. However, certain factors may hamper the growth of the market. Adverse effects associated with the usage of nebulizers such as infection are likely to impede the market’s growth. Other factors that may negatively impact the market include difficulties while transportation and additional administration time.
Koninklijke Philips N.V.’s Advanced Nebulizer to Reduce Treatment Time by 25%
Theravance Biopharma and Mylan signed a commercialization and development agreement on product expansion. Companies developed nebulized bronchodilator called YUPELRI (revefenacin) and extended its distribution to countries such as India and China.
Furthermore, the product is U.S. FDA approved for treating patients with COPD. Some of the key players functioning in the global nebulizers market are OMRON Corporation, PARI, Koninklijke Philips N.V., Becton, Allied Healthcare, Dickinson and Company, Agilent Technologies, Inc., Briggs Healthcare, and Medline Industries, Inc.
Among these, Philips announced the launch of the lightest and smallest hand-held nebulizer system called InnoSpire Go in October 2018. This system has the ability to improve treatment time by up to 25% and deliver medication in 4 minutes.
Browse Complete Report Details at
More Trending Topics from Fortune Business Insights:
Pisco Market 2019 Global Industry Size, Future Trends, Growth Key Factors, Demand, Business Share, Sales & Income and Opportunities Analysis by Outlook – 2026